Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-κB activity

Carcinogenesis

Volumn 17, Issue 11, 1996, Pages 2305-2309

  Li, Y ^a   Leung, L K ^a   Glauert, H P ^a   Spear, B T ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CIPROFIBRATE; DNA BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; LIVER; LIVER CARCINOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; RAT;

EID: 0029850963     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.11.2305     Document Type: Article

References (58)

1. Sen, R. and Baltimore, D. (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell, 46, 705-716.
2. Siebenlist, U., Franzoso, G. and Brown, K. (1994) Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol., 10, 405-455.
3. Miyamoto, S. and Verma, I.M. (1995) REL/NF-κB/IκB story. Adv. Cancer Res., 66, 255-292.
4. Verma, I.M., Stevenson, J.K., Schwarz, E.M., VanAntwerp, D. and Miyamoto, S. (1995) Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev., 9, 2723-2735.
5. Schreck, R., Rieber, P. and Baeuerle, P.A. (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J., 10, 2247-2258.
6. Pahl, H.L. and Baeurle, P.A. (1994) Oxygen and the control of gene expression. BioEssays, 16, 497-502.
7. Reddy, J.K. and Lalwani, N.D. (1983) Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit. Rev. Toxicol., 12, 1-58.
8. Hayashi, F., Tamura, H., Yamada, J., Kasai, H. and Suga, T. (1994) Characteristics of the hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator, in male F-344 rats. Carcinogenesis, 15, 2215-2219.
9. Huber, W., Kraupp-Grasl, B., Esterbauer, H. and Schulte-Hermann, R. (1991) Role of oxidative stress in age dependent hepatocarcinogenesis by the peroxisome proliferator nafenopin in the rat. Cancer Res., 51, 1789-1792.
10. Glauert, H.P., Srinivasan, S., Tatum, V.L., Chen, L.-C., Saxon, D.M., Lay, L.T., Borges, T., Baker, M., Chen, L.H., Robertson, L.W. and Chow, C.K. (1992) Effects of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cellular antioxidants and lipid peroxidation in rats. Biochem. Pharmacol., 43, 1353-1359.
11. Nakagawa, M., Ishihara, N., Shimokawa, T. and Kojima, S. (1987) Effect of clofibrate on lipid peroxidation in rats treated with aspirin and 4-pentenoic acid. J. Biochem., 101, 81-88.
12. Elliot, B.M. and Elcombe, C.R. (1987) Lack of DNA damaged or lipid peroxidation measured in vivo in the rat liver following treatment with peroxisome proliferators. Carcinogenesis, 8, 1213-1218.
13. Lake, B.G., Kozlen, S.L., Evans, J.G., Grey, T.J.B., Young, P.J. and Gangolli, S.D. (1987) Effect of prolonged administration of clofibric acid and di-(2-ethylhexyl)phthalate on hepatic enzyme activities and lipid peroxidation in the rat. Toxicology, 44, 213-228.
14. Conway, J.G., Tomaszewski, K.E., Olson, M.J., Cattley, R.C., Marsman, D.S. and Popp, J.A. (1989) Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643. Carcinogenesis, 10, 513-519.
15. Conway, J.G. and Popp, J.A. (1995) Effect of the hepatocarcinogenic peroxisome proliferator Wy-14,643 in vivo: no increase in ethane exhalation or hepatic conjugated dienes. Toxicol. Appl. Pharmacol., 135, 229-236.
16. Tomaszewski, K.E., Agarwal, D.K. and Melnick, R.L. (1986) In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators. Carcinogenesis, 7, 1871-1876.
17. Goel, S.K., Lalwani, N.D. and Reddy, J.K. (1986) Peroxisome proliferation and lipid peroxidation in rat liver. Cancer Res., 46, 1324-1330.
18. Perera, M.I.R., Katyal, S.L. and Shinozuka, H. (1986) Suppression of choline-deficient diet-induced hepatocyte membrane lipid peroxidation in rats by the peroxisome proliferators 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio (N-beta-hydroxyethyl)acetamide and di(2-ethylhexyl)phthalate. Cancer Res., 46, 3304-3308.
19. Marsman, D.S., Goldsworthy, T.L. and Popp, J.A. (1992) Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid. Carcinogenesis, 13, 1011-1017.
20. Price, S.C., Hinton, R.H., Mitchell, F.E., Hall, D.E., Grasso, T., Blane, G.F. and Bridges, J.W. (1986) Time and dose study on the response of rats to the hypolipidaemic drug fenofibrate. Toxicology, 41, 169-191.
21. Reddy, J.K., Lalwani, N.D., Reddy, M.K. and Quresh, S.A. (1982) Excessive accumulation of autofluorescent lipofuscin in the liver during hepatocarcinogenesis by methyl clofenapate and other hypolipidemic peroxisome proliferators. Cancer Res., 42, 259-266.
22. Mitchell, F.E., Price, S.C., Hinton, R.H., Grasso, P. and Bridges, J.W. (1985) Time- and dose-response study of the effects on rats of the plasticizer di(2-ethylhexyl)phthalate. Toxicol. Appl. Pharmacol., 81, 371-392.
23. Cattley, R.C., Conway, J.G. and Popp, J.A. (1987) Association of persistent peroxisome proliferation and oxidative injury with hepatocarcinogenicity in female F344 rats fed di(2-ethylhexyl)phthalate for 2 years. Cancer Lett., 38, 15-22.
24. Kasai, H., Okada, Y., Nishimura, S.S., Rao, M.S. and Reddy, J.K. (1989) Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res., 49, 2603-2605.
25. Takagi, A., Sai, K., Umemura, T., Hasegawa, R. and Kurokawa, Y. (1990) Significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats following short-term exposure to the peroxisome proliferators di(2-ethylhexyl)phthalate and di(2-ethylhexyl)adipate. Jpn. J. Cancer Res., 81, 213-215.
26. Takagi, A., Sai, K., Umemura, T., Hasegawa, R. and Kurokawa, Y. (1990) Relationship between hepatic peroxisome proliferation and 8-hydroxydeoxyguanosine formation in liver DNA of rats following long-term exposure to three peroxisome proliferators: di(2-ethylhexyl)phthalate, aluminum clofibrate and simfibrate. Cancer Lett., 53, 33-38.
27. Srinivasan, S. and Glauert, H.P. (1990) Formation of 5-hydroxymethyl-2′ deoxyuridine in hepatic DNA of rats treated with gamma-irradiation, diethylnitrosamine, 2-acetylaminofluorene or the peroxisome proliferator ciprofibrate. Carcinogenesis, 11, 2021-2024.
28. Takagi, A., Sai, K., Umemura, T., Hasegawa, R. and Kurokawa, Y (1991) Short term exposure to the peroxisome proliferators, perfluorooctanoic acid and perfluorodecanoic acid, causes significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats. Cancer Lett., 57, 55-60.
29. Huang, C.Y., Wilson, M.W., Lay, L.T., Chow, C.K., Robertson, L.W. and Glauert, H.P. (1994) Increased 8-hydroxydeoxyguanosine in hepatic DNA of rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid. Cancer Lett., 87, 223-228.
30. Hegi, M.E., Ulrich, D., Sagelsdorff, P., Richter, C. and Lutz, W.K. (1990) No measurable increase in thymidine glycol or 8-hydroxydeoxyguanosine in liver DNA of rats treated with nafenopin or choline-devoid low-methonine diet. Mutat. Res., 238, 325-329.
31. Cattley, R.C. and Glover, S.E. (1993) Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: relationship to carcinogenesis and nuclear localization. Carcinogenesis, 14, 2495-2499.
32. 2-generating peroxisomal fatty acyl-CoA oxidase. Proc. Natl Acad. Sci. USA, 92, 7080-7084.
33. FitzGerald, M.J., Webber, E.M., Donovan, J.R. and Fausto, N. (1995) Rapid DNA binding by nuclear factor κB in hepatocytes at the start of liver regeneration. Cell Growth Differ., 6, 417-427.
34. Cressman, D.E., Greenbaum, L.E., Hapber, B.A. and Taub, R. (1994) Rapid activation of post-hepatectomy factor nuclear factor kappa B in hepatocytes, a primary response in regenerating liver. J. Biol. Chem., 269, 30429-30453.
35. Poosch, M.S. and Yamasaki, R.K. (1986) Determination of peroxisomal fatty acyl-CoA oxidase activity using a lauroyl-CoA-based fluorometric assay. Biochim. Biophys. Acta, 884, 585-593.
36. Eacho, P.I., Lanier, T.L. and Brodhecker, C.A. (1991) Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883. Carcinogenesis, 12, 1557-1561.
37. Deryckere, F. and Gannon, F. (1994) A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques, 16, 405.
38. Costa, R.H. (1994) HNF3 protein family. In Tronche, R. and Yaniv, M. (eds), Liver Gene Expression. R.G. Landes Co., New York, pp. 183-205.
39. Tewari, M., Dobrzanski, P., Mohn, K.L., Cressman, D.E., Hsu, J.-C., Bravo, R. and Taub, R. (1992) Rapid induction in regenerating liver of RL/IF-1 (an IκB that inhibits NF-κB, RelB-p50, and c-Rel-p50) and PHF, a novel κB site-binding complex. Mol. Cell. Biol., 12, 2898-2908.
40. Green, S. (1992) Receptor-mediated mechanisms of peroxisome proliferators. Biochem. Pharmacol., 43, 393-401.
41. Tugwood, J.D., Issemann, I., Anderson, R.G., Bundell, K.R., McPheat, W.L. and Green, S. (1992) The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J., 11, 433-439.
42. Zhang, B., Marcus, S.L., Sajjadi, F.G., Alvares, K., Reddy, J.K., Subramani, S., Rachubinski, R.A. and Capone, J.P. (1992) Identification of a peroxisome proliferator-response element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase. Proc. Natl Acad. Sci. USA, 89, 7541-7545.
43. Nilakantan, V., Li, Y., Glauert, H.P. and Spear, B.T. (1996) Increased liver-specific catalase activity in transgenic mice. DNA Cell Biol., 15, 625-630.
44. Goeptar, A.R., Scheerens, H. and Vermeulen, N.P.E. (1995) Oxygen and xenobiotic reductase activities of cytochrome P450. Crit. Rev. Toxicol., 25, 25-65.
45. Lake, B.G., Gray, T.J.B., Körösi, S.A. and Walters, D.G. (1989) Nafenopin, a peroxisome proliferator, depletes hepatic vitamin E content and elevates plasma oxidised glutathione levels in rats. Toxicol. Lett., 45, 221-229.
46. Srinivasan, S.R., Chow, C.K. and Glauert, H.P. (1990) Effect of the peroxisome proliferator ciprofibrate on hepatic DNA synthesis and hepatic composition following partial hepatectomy in rats. Toxicology, 62, 321-332.
47. Boges, H.K. and Thurman, R.G. (1994) Peroxisome proliferators inhibit acyl CoA synthetase and stimulate protein kinase C in vivo. Toxicol. Appl. Pharmacol., 126, 233-239.
48. 2+-ATPase activity and mobilization of hepatic intracellular calcium by ciprofibrate, a peroxisome proliferator. Biochem. Pharmacol., 43, 595-605.
49. Orellana, A., Holuigue, L., Hidalgo, P.C. Faundez, V., Gonzalez, A. and Bronfman, M. (1993) Ciprofibrate, a carcinogenic peroxisome proliferator, increases the phosphorylation of epidermal-growth-factor receptor in isolated rat hepatocytes. Eur. J. Biochem., 215, 903-906.
50. Osumi, T. (1993) Structure and expression of the genes encoding peroxisomal β-oxidation enzymes. Biochimie, 75, 243-250.
51. Leung, L.K. and Glauert, H.P. (1996) Induction of cyclooxygenase-II by the peroxisome proliferator ciprofibrate in rats. FASEB J., 10, A146.
52. Ledwith, B.J., Manam, S., Troilo, P., Joslyn, D.J., Galloway, S.M. and Nichols, W.W. (1993) Activation of immediate-early gene expression by peroxisome proliferators in vitro. Mol. Carcinogen., 8, 20-27.
53. Goldsworthy, T.L., Goldsworthy, S.M., Sprankle, C.S. and Butterworth, B.E. (1994) Expression of myc, fos, and Ha-ras associated with chemically induced cell proliferation in the rat liver. Cell Prolif., 27, 269-278.
54. Hsieh, L.L., Shinozuka, H. and Weinstein, I.B. (1991) Changes in expression of cellular oncogenes and endogenous retrovirus-like sequences during hepatocarcinogenesis induced by a peroxisome proliferator. Br. J. Cancer, 64, 815-820.
55. Cherkaoui, M.M., Lone, Y.C., Corral-Debrinski, M. and Latruffe, N. (1990) Differential proto-oncogene mRNA induction from rats treated with peroxisome proliferators. Biochem. Biophys. Res. Commun., 173, 855-861.
56. Freedman, A.R., Sharma, R.J., Nabel, G.J., Emerson, S.G. and Griffin, G.E. (1992) Cellular distribution of nuclear factor κB binding activity in the rat liver. Biochem. J., 287, 645-649.
57. Schneider, W.C. (1957) In Colwick, S.P. and Kaplan, N.O. (eds), Methods Enzymol., Vol. III, pp. 680, Academic Press, Inc., New York.
58. Spear, B.T., Longley, T., Moulder, S., Wang, S.L. and Peterson, M.L. (1995) A sensitive lacZ-based expression vector for analyzing transcriptional control elements in eukaryotic cells. DNA Cell Biol., 14, 635-642.